The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Search

      
      View

Press Release / Mar 17, 2021
Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmicShowing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction

      View

Article / Jun 30, 2023
Excellence in pharmaceuticalsUSA Today, 30 June 2023

    Hovione Capacity ExpansionHovione is Growing

      View

Press Release / Sep 19, 2024
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy SolutionsCommitment to partnership and joint innovation for cell and gene therapies

      View

Press Clipping / Mar 19, 2020
Stepping up to the hand sanitizer shortageChemical companies, breweries, and perfumeries take to making and donating a vital commodity in short supply

      View

Press Release / Aug 23, 2022
Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticalsHovione today announced an extension of collaboration on Zerion’s Dispersome® technology into the nutraceutical/dietary supplements field.

      View

Press Clipping / Oct 27, 2025
Hovione Completes Initial $100M Investment Cycle to Expand U.S. Operations at New Jersey Manufacturing SiteInnovations in Pharmaceutical Technology, IPT Online, 27 October 2025

      View

News / Mar 10, 2021
It's B Corp MonthWe are proud to be a B Corporation.

      View

News / Apr 28, 2021
World Day for Safety and Health at WorkSafety First, Quality Always

      View

Press Clipping / Apr 06, 2023
Hovione 2023 CDMO Leadership Awards Winner InterviewOutsourced Pharma, April 2023

Browser not supported

Search

Types

Press Room

Categories

Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmic

Excellence in pharmaceuticals

Hovione Capacity Expansion

Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions

Stepping up to the hand sanitizer shortage

Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals

Hovione Completes Initial $100M Investment Cycle to Expand U.S. Operations at New Jersey Manufacturing Site

It's B Corp Month

World Day for Safety and Health at Work

Hovione 2023 CDMO Leadership Awards Winner Interview